Cargando…
Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important
BACKGROUND: Despite multiple available HIV prevention methods, the HIV epidemic continues to affect South Africa the most. We sought to understand willingness to use actual and hypothetical HIV prevention methods among participants enrolled in a preventative HIV vaccine efficacy trial in Soweto, Sou...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648553/ https://www.ncbi.nlm.nih.gov/pubmed/33160341 http://dx.doi.org/10.1186/s12889-020-09785-0 |
_version_ | 1783607136507396096 |
---|---|
author | Laher, Fatima Salami, Taibat Hornschuh, Stefanie Makhale, Lerato M. Khunwane, Mamakiri Andrasik, Michele P. Gray, Glenda E. Van Tieu, Hong Dietrich, Janan J. |
author_facet | Laher, Fatima Salami, Taibat Hornschuh, Stefanie Makhale, Lerato M. Khunwane, Mamakiri Andrasik, Michele P. Gray, Glenda E. Van Tieu, Hong Dietrich, Janan J. |
author_sort | Laher, Fatima |
collection | PubMed |
description | BACKGROUND: Despite multiple available HIV prevention methods, the HIV epidemic continues to affect South Africa the most. We sought to understand willingness to use actual and hypothetical HIV prevention methods among participants enrolled in a preventative HIV vaccine efficacy trial in Soweto, South Africa. METHODS: We conducted a qualitative study with 38 self-reporting HIV-uninfected and consenting 18–35 year olds participating in the HVTN 702 vaccine efficacy trial in Soweto. Using a semi-structured interview guide, five focus group discussions (FGDs) were held, stratified by age, gender and sexual orientation. The FGDs were composed of: (i) 10 heterosexual women aged 18–24 years; (ii) 9 heterosexual and bisexual women aged 25–35 years; (iii & iv) heterosexual men aged 25–35 years with 7 in both groups; and (v) 5 men aged 18–35 years who have sex with men. FGDs were audio-recorded, transcribed verbatim, translated into English and analysed using thematic analysis. RESULTS: We present five main themes: (i) long-lasting methods are preferable; (ii) condoms are well-known but not preferred for use; (iii) administration route of HIV prevention method is a consideration for the user; (iv) ideal HIV prevention methods should blend into the lifestyle of the user; and the perception that (v) visible prevention methods indicate sexual indiscretion. CONCLUSIONS: The participants’ candour about barriers to condom and daily oral pre-exposure prophylaxis (PrEP) use, and expressed preferences for long-lasting, discreet, lifestyle-friendly methods reveal a gap in the biomedical prevention market aiming to reduce sexually acquired HIV in South Africa. Product developers should consider long-acting injectable formulations, such as vaccines, passive antibodies and chemoprophylaxis, for HIV prevention technologies. Future innovations in HIV prevention products may need to address the desire for the method to blend easily into lifestyles, such as food-medication formulations. |
format | Online Article Text |
id | pubmed-7648553 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-76485532020-11-09 Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important Laher, Fatima Salami, Taibat Hornschuh, Stefanie Makhale, Lerato M. Khunwane, Mamakiri Andrasik, Michele P. Gray, Glenda E. Van Tieu, Hong Dietrich, Janan J. BMC Public Health Research Article BACKGROUND: Despite multiple available HIV prevention methods, the HIV epidemic continues to affect South Africa the most. We sought to understand willingness to use actual and hypothetical HIV prevention methods among participants enrolled in a preventative HIV vaccine efficacy trial in Soweto, South Africa. METHODS: We conducted a qualitative study with 38 self-reporting HIV-uninfected and consenting 18–35 year olds participating in the HVTN 702 vaccine efficacy trial in Soweto. Using a semi-structured interview guide, five focus group discussions (FGDs) were held, stratified by age, gender and sexual orientation. The FGDs were composed of: (i) 10 heterosexual women aged 18–24 years; (ii) 9 heterosexual and bisexual women aged 25–35 years; (iii & iv) heterosexual men aged 25–35 years with 7 in both groups; and (v) 5 men aged 18–35 years who have sex with men. FGDs were audio-recorded, transcribed verbatim, translated into English and analysed using thematic analysis. RESULTS: We present five main themes: (i) long-lasting methods are preferable; (ii) condoms are well-known but not preferred for use; (iii) administration route of HIV prevention method is a consideration for the user; (iv) ideal HIV prevention methods should blend into the lifestyle of the user; and the perception that (v) visible prevention methods indicate sexual indiscretion. CONCLUSIONS: The participants’ candour about barriers to condom and daily oral pre-exposure prophylaxis (PrEP) use, and expressed preferences for long-lasting, discreet, lifestyle-friendly methods reveal a gap in the biomedical prevention market aiming to reduce sexually acquired HIV in South Africa. Product developers should consider long-acting injectable formulations, such as vaccines, passive antibodies and chemoprophylaxis, for HIV prevention technologies. Future innovations in HIV prevention products may need to address the desire for the method to blend easily into lifestyles, such as food-medication formulations. BioMed Central 2020-11-07 /pmc/articles/PMC7648553/ /pubmed/33160341 http://dx.doi.org/10.1186/s12889-020-09785-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Laher, Fatima Salami, Taibat Hornschuh, Stefanie Makhale, Lerato M. Khunwane, Mamakiri Andrasik, Michele P. Gray, Glenda E. Van Tieu, Hong Dietrich, Janan J. Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important |
title | Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important |
title_full | Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important |
title_fullStr | Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important |
title_full_unstemmed | Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important |
title_short | Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important |
title_sort | willingness to use hiv prevention methods among vaccine efficacy trial participants in soweto, south africa: discretion is important |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648553/ https://www.ncbi.nlm.nih.gov/pubmed/33160341 http://dx.doi.org/10.1186/s12889-020-09785-0 |
work_keys_str_mv | AT laherfatima willingnesstousehivpreventionmethodsamongvaccineefficacytrialparticipantsinsowetosouthafricadiscretionisimportant AT salamitaibat willingnesstousehivpreventionmethodsamongvaccineefficacytrialparticipantsinsowetosouthafricadiscretionisimportant AT hornschuhstefanie willingnesstousehivpreventionmethodsamongvaccineefficacytrialparticipantsinsowetosouthafricadiscretionisimportant AT makhaleleratom willingnesstousehivpreventionmethodsamongvaccineefficacytrialparticipantsinsowetosouthafricadiscretionisimportant AT khunwanemamakiri willingnesstousehivpreventionmethodsamongvaccineefficacytrialparticipantsinsowetosouthafricadiscretionisimportant AT andrasikmichelep willingnesstousehivpreventionmethodsamongvaccineefficacytrialparticipantsinsowetosouthafricadiscretionisimportant AT grayglendae willingnesstousehivpreventionmethodsamongvaccineefficacytrialparticipantsinsowetosouthafricadiscretionisimportant AT vantieuhong willingnesstousehivpreventionmethodsamongvaccineefficacytrialparticipantsinsowetosouthafricadiscretionisimportant AT dietrichjananj willingnesstousehivpreventionmethodsamongvaccineefficacytrialparticipantsinsowetosouthafricadiscretionisimportant |